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Preface
Medical record abstraction is the process in which a human manually searches through a medical record
to identify data required for a secondary use. Abstraction involves some direct matching of information
found in the record to the data required, but also includes operations on the data such as categorizing,
coding, transforming, interpreting, summarizing, and calculating. The abstraction process results in a
summary of information about a patient for a specific secondary data use. Medical Record Abstraction
remains a primary mode of data collection in clinical research, quality improvement, performance
measurement, disease surveillance, and other secondary data uses.
While hundreds of articles mention factors that may impact the accuracy of abstracted data, the
information in the literature until now has not been synthesized, and the majority of the work has been
done in the absence of a theoretical framework.
Information generation, collection, and representation are central to informatics. Generation, collection,
and representation impact data and information quality; in turn, data and information quality impact use.
Medical Record Abstraction is about the interaction of humans with the processes, tools, representations,
and environment in which the abstraction occurs. In medical record abstraction, a human being is an
agent in the collection and transformation of data. That human-data-representation interaction is an
informatics problem that, until now, has not yet been addressed from an informatics perspective.
The work presented here was motivated by the lack of consensus and lack of evidence supporting
methods used in the collection and management of clinical research data and their impact on the quality
of the data. This work began with a quantitative literature review and pooled analysis of data error rates
reported in the clinical trial and registry literature. This first paper included in this compilation associated
medical record abstraction with the highest error rates of the data collection and processing methods
common in clinical research. Thus, data quality in medical record abstraction became the focus of further
investigation.
The second paper in the compilation, a formal concept analysis of data quality, was necessary for further
investigation of data quality in medical record abstraction. The concept analysis clarified the
multidimensionality of data quality, and focused my work on the dimension of data accuracy, i.e.,
correctness of the data values.
My study of data accuracy in medical record abstraction was initiated with a review and formal synthesis
of the medical record abstraction literature. Working with the literature helped identify appropriate
theoretical frameworks and led the way to a classification system for factors impacting the accuracy of
medical record abstraction. The factors impacting data accuracy in medical record abstraction reported in
the literature were assed (content validity) through a two cohort, four round Delphi process. The third
paper in this compilation presents the results of this work.
The fourth and final paper in this compilation investigates one factor, cognitive load, consistently
indicated in the literature as impacting data accuracy in medical record abstraction. Representational
Analysis methodology was applied to asses the possibility that abstractor cognitive load during
abstraction reaches published limits of human cognition. This work demonstrated that cognitive load
during abstraction from characteristics of the data elements alone, not only reaches, but in 9% of the data
elements, exceeds human cognitive limits.
This work lays the groundwork for additional research and furthers both the science of informatics and
the clinical and translational research to which it is applied.
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Abstract
We present a literature review and secondary analysis of data accuracy in clinical research and
related secondary data uses. A total of 93 papers meeting our inclusion criteria were categorized
according to the data processing methods. Quantitative data accuracy information was abstracted
from the articles and pooled. Our analysis demonstrates that the accuracy associated with data
processing methods varies widely, with error rates ranging from 2 errors per 10,000 files to 5019

Fo

errors per 10,000 fields. Medical record abstraction was associated with the highest error rates
(70–5019 errors per 10,000 fields). Data entered and processed at healthcare facilities had

rP

comparable error rates to data processed at central data processing centers. Error rates for data
processed with single entry in the presence of on-screen checks were comparable to double

ee

entered data. While data processing and cleaning methods may explain a significant amount of

rR

the variability in data accuracy, additional factors not resolvable here likely exist.

ie

ev

Abstract Word Count: 150 words

Key Words: Data management; Data quality; Clinical research; Registries; Electronic data

w

processing; Chart review; Medical record abstraction; Data collection
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Introduction
Computers have been used in clinical research since the early 1960s, although initial efforts to
integrate them into such efforts were experimental and sporadic [1,2]. The early application of
computers to health-related research spawned a plethora of methods for collecting and preparing
data for analysis [3,4]. These functions, which are central to the field of clinical research
informatics, are evaluated by metrics of cost, time, and quality [5]. While cost and time affect the
feasibility of research, and timeliness is certainly critical to the conduct and oversight of

Fo

research, the scientific validity of research conclusions depends on data quality in general and

rP

data accuracy in particular [6].

Reports on data accuracy assessments begin in the late 1970s [7] and continued throughout

ee

the 1980s [8-12]. Although data accuracy is likely attributable to how data are collected, entered,
and cleaned, or otherwise processed, no systematic reviews of the clinical research data quality

rR

literature have been conducted to date. In 2002, Arts published a review of data quality in

ev

medical research registries [13]. Although a significant contribution, Arts’ work was limited in
scope to registries and did not include other secondary uses, such as clinical trials.

ie

Several texts describe approaches to general data quality management independent of the

w

domain area of the application [14-17]. These works focus on general methods for assessing and
documenting data quality, as well as methods for storing data in ways that maintain or improve
their quality. As such, the works abstract above data collection and processing methods
applicable to specific industries and types of data. They provide little to no guidance to
investigators and research teams planning a clinical research endeavor or attempting to
operationalize data collection and management.
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Background
Many authors in the clinical research arena lament the paucity of published information
regarding clinical trials data quality [5,6,8,12,18-26]. While most authors point out that
conclusions drawn from studies depend on data quality (and the underlying data collection and
management methods), others label the associated tasks mundane [27,28]. This perception has
perhaps resulted in the minimal degree of investigation and associated low number of
publications on the topic of data collection and management, compared with other areas of

Fo

clinical research and informatics methodology. An initial step in seeking such information and

rP

providing guidance to investigators and research teams is a thorough review and synthesis of the
relevant published literature.

ee

With the current rapid influx of new technology into healthcare and clinical research, the
quality of data quality achievable using available methods becomes even more important; e.g.,

rR

learning from the past, and providing benchmarks for new technology evaluation [29]. Many

ev

unresolved issues exist with respect to data quality in clinical research, including a thorough
understanding of the accuracy and variability of current data processing methods. Thus, a

ie

synthesis of information about clinical research data quality from the literature is a critical

w

contribution to both clinical research informatics and clinical and translational research.
Historically, data processing methods used across clinical research show significant
variability [3,4,30]. Briefly, according to Medical Subject Headings (MeSH) terminology,
registries are the ‘‘systems and processes involved in the establishment, support, management,
and operation of registers (sic), e.g., disease registers.” In a 2008 paper, Drolet distinguishes
registries from simple databases or other non-registry data repositories and presents six criteria
for medical data registries [31]. Not evident in his definition, however, are the wide variety of
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data processing methods used for medical data registries. These include: 1) chart review and
abstraction versus direct electronic acquisition from electronic medical records; 2) use of vended
data collection systems by local healthcare facilities (e.g., data entry and cleaning in local
systems versus Web-based data entry and cleaning in a centrally hosted system); 3) use of paper
data collection forms and central processing; and 4) single versus double data entry. Data
cleaning methods also vary greatly, from use of “reports of things to consider for the next data
submission,” to on-screen checks during data entry, to post-entry batch data processing.

Fo

Except for the ongoing transition from paper-based data collection to Web-based collection,

rP

methods used to gather and process data for industry-sponsored clinical trials performed in
support of marketing authorization have remained fairly uniform over the 30-year span of the

ee

literature base. Generally, in this highly regulated variety of clinical research, data are abstracted
from patient charts, then transcribed onto either paper forms or electronic data capture (EDC)

rR

systems. Where paper forms are used, data are forwarded to a central data center, double-entered,

ev

and subjected to data cleaning checks. Discrepancy reports are sent to the clinical investigational
sites, and resolutions to any queries are received in return; based on these responses, the database

ie

is then updated. In contrast, data collected on modern EDC trials are generally single-entered at

cleaning checks.

w

clinical investigational sites in centrally hosted Web-based systems that employ on-screen data

Data collection and processing for clinical research funded by non-industry means (such as
trials funded by governmental and foundational resources), varies widely. As with registries and
market-oriented clinical research, the process typically starts with chart review, also called
medical record abstraction (or simply “abstraction”). Small early-phase or low-budget projects,
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however, often employ commercially-available spreadsheets for data collection and
management, and manual data review for data cleaning.
Unfortunately, while use of spreadsheets in research is ubiquitous, there are few reports on
how this affects data quality [32-36]. Both small and mid-size projects often use Microsoft
Access (Redmond, WA) or similar pseudo-relational data systems that provide utilities for
creating data entry screens, a scripting language for error checks, and a data storage mechanism.
Data entry in such systems tends to be single entry, with a combination of on-screen and post-

Fo

entry data cleaning.

rP

Similarly, some investigators choose to enter data directly into statistical analysis packages
such as SPSS (Chicago, IL) or SAS (Cary, NC). Larger government- and foundation-funded

ee

projects tend to use custom data collection systems developed specifically for a given project;
many of these use relational database management systems. There has been a recent trend in

rR

government-funded projects toward specialized, vended clinical data management systems

data processing methodologies.

ie

ev

employed in regulated clinical trials. These systems support multiple workflows, and different

Thus, historically, data collection and processing methods have varied greatly across types of

w

clinical research, and there has been little comparative evaluation of different methods and
technologies. Key events, however, signal an increasing convergence in methods. These include:
1) industry contract research organizations serving as data centers for government-funded
research; 2) use of central data centers for government-funded work; 3) a recent increase in
academic membership in the historically industry-based Society for Clinical Data Management;
4) National Institutes of Health (NIH) contract and grant solicitations that require compliance
with industry regulations; and 5) government adoption of vended clinical data management
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systems [30]. Convergence of such great variability necessitates comparative evaluation of
methods and technologies of data collection and management with respect to cost and data
quality [29].
Significant variability also exists in quantitative methods for assessing data accuracy across
clinical research and other secondary data uses [13,37,38]. Data accuracy has often been
measured in terms of database error rates (registries also often assess percent completeness, and,
thus evaluate data quality in terms of data accuracy and completeness). The error rate is defined

Fo

in the Good Clinical Data Management Practices document (GCDMP) as the number of errors

[39].

ee

rP

divided by the number of data values inspected [37], a method used in other industries as well

number of errors
number of values inspected

ev

rR

Error rate

As described in the GCDMP and elsewhere [40], there are significant differences in the way

ie

errors and values are inspected and counted. Based on these counting differences, the error rates

w

obtained can differ by a factor of two or more [37,38]. In addition, differences in how error rates
are reported (e.g., as raw counts, errors per record, or errors per 10,000 fields), necessitate
scaling and normalization of the values reported in the literature before meaningful comparisons
can be made.
Assessment and quantification of data accuracy is crucial to scientific inquiry. Errors
increase variance, which in turn diminishes statistical power. Three papers report simulations of
power loss or related constructs for different error rates [23,41,42]. Rostami et al. provide an
analytical solution for the impact of database errors on reliability and show the resulting increase
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in sample size necessary to compensate for the loss of statistical power for given error rates in
the dependent analysis variable [40].
The effect of errors on data quality is dependent on the variable in which the error occurs;
i.e., in major independent or dependent variables or covariates [43]. The impact is also dependent
on the robustness of the particular analytical method used. Thus, there is no regulatory or onesize-fits-all standard error rate for clinical research. A 1999 Institute of Medicine report
emphasizes this by defining quality data in clinical research as “data that support the same

Fo

conclusions as error free data [6].”

rP

One balancing factor, the cost and time associated with cleaning data, can account for
upwards of 10%–20% of the cost of a clinical trial [44]. Thus, cleaning data to appropriate

ee

quality levels and not beyond is clearly the target. To support this, a thorough characterization of
data processing methods with respect to data accuracy is clearly needed to identify the most cost-

rR

effective balance. To that end, we undertook a review and secondary analysis of the relevant

ie

ev

literature to characterize data processing methods with respect to quality.

Purpose

main questions comprise the focus of this research:

w

We sought to synthesize the literature on data quality in clinical research and registries. Four

1. How much, and what kind of, quantitative data quality information is reported in the
literature?
2. What data collection and processing methods are described? Secondarily, is the
information applicable to newer data processing methods (such as Web-based EDC) in
clinical research?
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3. Do error rates differ by data processing method? If so, how and by how much?
4. Are some data processing methods inherently more variable than others? If so, to what
extent?

Methods
Criteria for inclusion of manuscripts
The criteria for inclusion in this analysis were as follows: 1) articles must be manuscripts

Fo

published in peer review journals indexed for retrieval, be referenced by such, or be publicly

rP

available; 2) have a focus on secondary data use (e.g., clinical research, quality improvement,
surveillance, research registries); 3) the database error rate must be presented or resolvable (e.g.,

ee

via number of errors identified and number of fields inspected, or must contain sufficient
information to calculate); 4) must describe how the data were processed (e.g., optical scanning,

rR

single or double entry); 5) must be written in the English language; and 6) must be a primary

ev

source for the error rate. The following parameters were optional: data cleaning method, location
of data processing (central data center vs. local healthcare facility), gold standard used, and

w

Information retrieval

ie

scope of method of comparison.

A PubMed search on the Medical Subject Heading (MeSH) terms “data quality” AND (registry
or “clinical trial”) produced 350 citations through 2008. Review of the 350 abstracts produced
54 articles deemed likely to contain quantitative information about data quality; the full text of
these 54 articles was reviewed. PubMed related links and secondary and tertiary references from
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the 54 articles identified an additional 70 articles of interest. After full-text review of the 124
articles, 93 articles met our criteria and were used in this analysis.

The literature
The literature in this area spans publication dates from 1978–2008. The clinical research data
quality literature base is fragmented across 60 distinct journals, including medical specialty
journals, statistics journals, clinical research journals, and informatics journals. Journals with

Fo

more than one article meeting our inclusion criteria are listed in Table 1.

rP

Although articles could be categorized by the clinical area of interest, categorization by type
of secondary use and data processing method is more germane to our investigation. The literature

ee

is categorized into major groupings according to type of secondary use, data processing method,
and data accuracy assessment method in Table 2. The categories in Table 2 represent

rR

combinations of common factors and are not mutually exclusive; thus, some articles appear in

Data collection and analysis

ie

ev

more than one category. Importantly, all articles used in our analysis are included in Table 2.

w

Three types of data were collected from each article: 1) information about how data were processed
[Table 3]; 2) information about how data quality was measured [Table 4]; and 3) number of errors
and number of fields inspected. Prior to quantitative data analysis, the factors shown in Tables 3
and 4 were developed in a qualitative, iterative manner during the review of the articles. Attributes
of the data processing and quality measurement as reported were noted as each article was read.
Natural groupings were organized into the categories displayed in Tables 3 and 4. These categories
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were later explored in the analysis to ascertain which (if any) of the factors might affect data
quality.
In the literature, data quality is presented in several different ways, including overall
agreement, kappa, (ț), number of erroneous fields per number of records reviewed, number of
erroneous fields per number of fields (values) reviewed, number of errors per number of
keystrokes, and specificity and sensitivity. Traditionally, where a gold standard is used for
comparison, overall agreement is reported, whereas if the researcher believes there is no gold

Fo

standard (often the case of two independent raters), ț is reported. We abstracted the number of

rP

errors reported and the total number of data fields (values) inspected. In one case, an author was
contacted to confirm the number of fields inspected. Four articles [9,41,88,102] presented only

ee

normalized error rates as errors per 10,000 fields; for these, the denominator was assumed for the
total number of fields inspected. The number of errors and number of fields inspected were used

rR

to calculate normalized error rates (number of errors per 10,000 fields) based on the

ev

recommendations in GCDMP [37].

Each article described a data quality assessment of one or more databases. Where error rates

ie

for more than one database or assessment were provided in an article, each is included in this

w

analysis. Likewise, in some articles, error rates were reported for more than one process step; for
example, medical record to Case Report Form (CRF), CRF to first entry, first entry to second
entry, or CRF to clean file. Where error rates for multiple data processing steps were provided,
we include them here; thus, the number of data points is higher than the number of reviewed
papers. A total of 22 articles reported results for more than one processing step, process or
database [9,11,13,22,32,54,55,63,64,66,74,79-81,83-85,87,96,102,114,121], providing a total of
125 data points.
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For consistency, one rater was used to abstract the error rate information from the articles
(MN). A sample of the manuscripts included in the analysis, comprising 10% of the total, was reevaluated following the initial abstraction to assess reliability. For the sample, the time between
the initial and intra-rater reliability review was at least 1 year. Intra-rater reliability, calculated as
percent difference, was used to gauge reliability of the data. The intra-rater reliability for number
of errors, number of fields, and error rate were 85%, 97%, and 86% respectively. In addition, a
second rater (CJ) reviewed the same intra-rater reliability sample, with comparable results. In

Fo

light of the underlying variability in the data, the variability in error rate calculation methods

rP

currently in use, and the aims of this study, these were considered reasonable. In addition, they
are comparable to those in a similar review paper of errors in electronic medical records [123].

ee

Two reviews of data accuracy in electronic medical records report variability in the methods
used to measure accuracy [123,124]. Both reviews concluded that the methodological variability

rR

was sufficiently significant to preclude pooled analysis. However, Hogan and Wagner stated that

ev

assessment methods in the field of clinical research were more uniform, an assessment similar to
our own. We therefore pursued a pooled analysis and normalized error rates from the literature.

ie

From this analysis, we present descriptive statistics and confidence intervals.

w

Results

The data obtained from our literature review are displayed in Figure 1, which shows all 125 data
points normalized as number of errors per 10,000 fields and demonstrates the dispersion over
time of the health-related research literature with respect to data accuracy. Database error rates
ranged from 2–5019 errors per 10,000 fields. This three orders-of-magnitude range necessitated a
logarithmic display. There appears to be no pattern in the year-to-year reporting. It is reasonable
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to assume that if adoption and implementation of new technology tended to increase data quality,
such a trend would be evident in the graph. One possible explanation for the lack of such a trend
is that adoption and implementation of new technology throughout the years has not increased
the data accuracy. Another possibility is that data accuracy is not considered in new technology
evaluation and implementation.
In order to explore possible differences in data quality for different data processing methods,
data were categorized according to the method used to process the data, shown in Figure 2.

Fo

Source-to-database and source-to-CRF were combined into a single category labeled abstraction

rP

based on: 1) some of the articles reported error rates for abstraction directly to an electronic data
collection form; i.e., no separate data entry step, and 2) the central tendency and dispersion of the

ee

two processes being similar. Data have been horizontally jittered to more fully display the data
set. The median (horizontal bar) is overlaid on each group. The source-to-database error rates

rR

ranged from 82–5019 errors per 10,000 fields; the source-to-CRF error rates ranged from 70–

ev

3360 errors per 10,000 fields. Optical scanning error rates ranged from 2–1106 errors per 10,000
fields. Single-entry error rates ranged from 4–650 errors per 10,000 fields, while double-entry

ie

error rates ranged from 4–33 errors per 10,000 fields. Additional descriptive statistics are

w

provided in Table 5.

Several salient features are apparent in Figure 2. First, ordered by the median, medical record
abstraction is associated with the highest error rate, followed by optical methods and single
entry, while double data entry, the least complex and most controlled, is associated with the
lowest error rate. Importantly, abstraction, optical methods, and single entry all are associated
with significant variability. Notably, the error rates reported for both medical record abstraction
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and optical methods span three orders of magnitude. For optical methods, there were too few
data points to support a subgroup analysis.
For single entry, there were both a sufficient number of data points and detail regarding
different methods to perform a subgroup analysis (Figure 3), in which we examined the effects of
aspects of data processing reported in the literature, including the presence of on-screen checks,
use of batch data cleaning, and the location of data processing. These variations are examined
here because they represent key data processing options in current Web-based EDC systems, but

Fo

as they constitute small subgroups, any findings from their analysis should be considered only as

rP

indicators of potential trends. For example, labels such as “batch data cleaning” or “on-screen
checks” were only applied where the original manuscript specifically so noted; therefore, the

ee

other data points may or may not have employed batch data cleaning or on-screen checks.
Location of data processing (e.g., at local facilities versus central data centers), was discernable

rR

from all articles.

ev

Analysis of the subgroup data revealed the following patterns. Location of data processing
appeared to have little effect on data accuracy. When both distributed and centrally entered data

ie

are considered together, on-screen checks (OSC) were associated with a decrease in average

w

error rates, from 158 errors per 10,000 fields to 23; in addition, variability was correspondingly
decreased from 211 errors per 10,000 fields to 15 (the categories labeled “All” in Figure 3). The
trend is the same for data entered at clinical sites (“distributed OSC” in Figure 3), where onscreen checks were associated with a decreased average error rate of 28 errors per 10,000 fields,
comparable to the average quality obtained from double entry. Importantly, the data presented in
Figure 3 represent only data processing accuracy—they do not include errors that may result
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from upstream processes (such as errors in the medical record itself or errors arising from
abstraction process). Descriptive statistics for Figure 3 are shown in Table 6a.
The predominant method of clinical research data collection in the near future will likely be
Web-based EDC. Due to the importance of this particular model, articles reporting data accuracy
from similar data processing configurations (e.g., central versus distributed data processing in the
presence of OSC), were examined (Figure 4). Similar to the single-entry subgroup results, this
analysis showed little difference in error rates for centrally versus locally processed data. Thus,

Fo

the EDC model is likely capable of providing accuracy comparable to that of centrally processed

rP

data. As in Figure 3, the data presented in Figure 4 represent only data processing accuracy.
Descriptive statistics are provided in Table 6b.

ee

Finally, we examined the effect of batch data cleaning on error rates. This analysis was
performed on the entire data set. Only 19 of the studies we examined reported on whether batch

rR

data cleaning techniques were employed. We conservatively grouped articles that explicitly

ev

stated that no batch data cleaning was used with articles that made no mention of batch data
cleaning. This analysis (Figure 5) showed that batch data cleaning was associated with lower

ie

error rates and decreased variability (descriptive statistics are reported in Table 7). Databases

w

employing batch data cleaning were more likely to use central data processing and double data
entry. In addition, the upper mode of the batch-cleaned data, with the exception of one data
point, consisted of medical record abstraction studies.

Discussion
Over the last 30 years, empirical data accuracy assessments have been reported in the literature.
Although there have been articles that summarized results reported in multiple papers
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[5,13,21,22], there has been little synthesis, and this area of inquiry still lacks a theoretical
framework. Further, although notable exceptions exist [11,22,33,59,79,84,85,87,92], little
evidence has been obtained regarding the relative accuracy of different data processing methods.
Characterizing the factors that affect data accuracy, as well as the differences in accuracy among
popular methods (as done inductively here), serves as the beginning of such a framework.

Medical record abstraction

Fo

First and foremost, our results indicate that medical record abstraction is associated with error

rP

rates an order of magnitude greater than that attributable to “downstream” data processing
techniques. These results support claims that medical record abstraction is the most significant

ee

source of error in clinical research [21,125]. This is unfortunate, because medical record
abstraction remains the dominant method of data collection in retrospective and prospective

rR

research, as well as in the fields of safety surveillance and healthcare quality improvement.

ev

Although position papers and reports of empirical results exist, the reasons for high error
rates associated with medical record abstraction have not been systematically studied, and the

ie

mechanisms are not understood. Empirical studies suggest that there is significant variability in

w

the abstraction and quality control processes used [126,127]; these different methods, process
aids and quality control activities could be responsible for the amount of variation observed.
Likewise, the reliance on human performance and associated underlying cognitive processes
could be responsible for some or all of the variability.
Several authors have further explored these underlying reasons for the high variability in
abstraction [56,81,125-129]. Differences related to therapeutic area, such as type of data
collected, patient acuity, and chart complexity, are one source of variability [81,129].
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Additionally, variables recorded at multiple time points and at multiple places in the patient
chart, as well as those that require the abstractor to interpret or synthesize information into a
score, are known to be more subject to error [81], as are variables requiring the use of clinical
judgment on the part of the abstractor [128]. Further, although many investigators proceed on the
premise that charts provide correct data [130], there are a significant number of errors,
inconsistencies, and omissions in the charts themselves [126,130]. Such chart errors, while not
arising from abstraction, nonetheless further increase the variability in abstracted data, and are

Fo

not measured or accounted for by current data quality assessment practices [129]. Exploring the

rP

causes of this variability is an important area for future research. Unfortunately, while there are
sufficient data points, there is insufficient information in the literature about the medical record

ee

abstraction methods to further investigate possible causes for the variability in a subgroup
analysis.

rR

Importantly, medical record abstraction errors are less likely to be detected by downstream

ev

data processing such as data entry or programmatic data cleaning. For example, an incorrect but
plausible value chosen from the medical record will not be detected by valid range checks.

ie

Medical record abstraction errors that result in plausible values will only be detected through

will likely remain undetected by this method.

w

comparison to the medical record; i.e., re-abstraction, while errors in the medical record itself

Although differences in medical charts among sites complicate the construction of
abstraction guidelines for multicenter research, differences between abstractors are so significant
that most authors have recommended and employed detailed abstraction guidelines for each
variable [56,81,125-128]. Abstraction guidelines are used in national performance measurement
and healthcare quality improvement programs, such as the Joint Commission specifications for
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performance measures [131,132] and the Healthcare Effectiveness Data and Information Set
(HEDIS) roadmap [133].
However, such guidelines, which constitute a primary mechanism for preventing abstraction
errors, are not often used in clinical trials. Instead, less specific form-completion instructions are
employed. These instructions often do not specify from where in the medical record a particular
value should be obtained, or provide guidance in the case of multiple available or missing values.
In a process called source data verification, data for a sample of subjects are compared to the

Fo

chart, typically without calculating an error rate [81,134]. It is unfortunate that the association of

rP

clinical trials with prospective data collection further fuels the perception that abstraction or
chart review is not a factor in data accuracy when in fact the chart is the source of most clinical

ee

research data, and abstraction from the chart is the part of the data collection process most
subject to error [21,125]. Despite recommendations for measuring and monitoring data quality

rR

from the medical record abstraction process [29,127,128], abstraction error usually remains

ie

Optical methods

ev

unquantified [29,40,81,134].

w

Although methods such as optical character recognition (OCR) and optical mark recognition
(OMR) have been touted as a faster, higher-quality or less resource-intensive substitute for
manual data entry [27,58,62,84,92,93,135-137], others have reported error rates with optical
methods that were three times higher than manual keyboard data entry [138]. As was the case
with medical record abstraction, optical methods were associated with a variability of three
orders of magnitude in accuracy, which is clearly unacceptable for a data entry method. Such
variability may be influenced by: the presence and type of data cleaning employed in processing
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the optical scans; use of post-entry visual verification or pre-entry manual review; training of
form completers on handwriting; differences in form compatibility with the software; software
configuration (e.g., recognition engine); and variations in data quality assessment methods. For
example, some implementations employ programmatic checks and visual verification of fields
labeled with low confidence from the OCR or OMR engine. In addition, the different engines
employed need to be calibrated for each implementation.
Reports on the accuracy of optical methods uniformly showed greatest accuracy with mark

Fo

objects (check boxes, fill-in-bubbles), followed by numeric fields [27,92,138]. The accuracy of

rP

free-text fields was the lowest of the three field types [58,92,138]. Some authors have reported
comparisons of optical methods with double or single data entry [32,62,92,138]; however,

ee

because of the variability in the reported accuracy, together with the relative paucity of reports
and the lack of sufficient detail regarding associated data processing methods, we did not

rR

summarize these findings separately. The results here suggest that with appropriate adjunct data

ev

cleaning processes, optical methods can achieve comparable accuracy to single-entered data. The
wide variability also suggests that an a priori quantitative assessment of data accuracy and total

ie

cost is necessary when an optical system is newly installed or upgraded.

w

Keyboard entry

A review of the literature provides the opportunity for analyzing different variations on key
entry, including single entry, single entry with on-screen data checks, and double entry. We
undertook these comparisons because single entry is widely used with Web-based EDC, the
extent of OSCs is at the discretion of the study team, and there is little evidence to guide practice.
Our analysis demonstrates that single entry with OSC is associated with accuracy comparable to
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that obtained with double data entry. However, single entry alone was associated with an average
of more than 100 errors per 10,000 fields, compared with an average of 23 errors per 10,000
fields with OSC. The subgroup analysis of single entry provides a plausible explanation for the
variability. This is an important finding, because large amounts of data are collected from
research sites via Web-based systems, including entry of abstracted data into Web-based
systems, clinicians entering data in electronic health records, and data collected directly from
patients via hand-held devices. Due to the problem of “alert fatigue,” however, OSC may not be

Fo

feasible in electronic medical records, where clinical alerts will often be a higher priority. The

Central versus distributed

ee

rP

question of alert fatigue in these systems is an important topic for further research.

Given the movement toward Web-based EDC and the use of electronic medical record data in

rR

clinical research, the question of the relative accuracy between data entered centrally versus

ev

distributed data entry is an important one. Our results show that in the presence of OSCs, data
entered centrally have marginally better accuracy compared with data entered at investigational

ie

sites. However, with the exception of one outlier, the points for distributed data entry fell within

w

the range of the centrally entered data. Given the variability in implementations of OSC (e.g.,
number and type of checks), these results suggest that data quality equivalent to that of centrallyentered data can be obtained through distributed methods, and that more information is needed to
guide practice.
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Batch data cleaning
Batch data cleaning was associated with a decrease in error rates of more than 300 errors per
10,000 fields, as well as an almost 50% decrease in variability. In addition, an internal analysis at
our institution noted that on average, values for 1%–2% of any variable changed based on batch
data cleaning. Although this number was based on programmed batch checks and double entered
data, the number is consistent with the results from the literature review, and likely to be
considerably higher for single-entered data. However, as noted earlier, use of batch data cleaning

Fo

was reported in only 19 of the cases reviewed in this analysis (manuscripts that did not report

rP

batch cleaning were conservatively assumed not to have used it). Importantly, batch data
cleaning is resource-intensive to implement, because it requires programming logic for each

ee

suspected discrepancy, the number of which are exponentially combinatorial with the number of
data fields collected. In addition, the asynchronous identification of data discrepancies (i.e., after

rR

data entry) necessitated by batch data cleaning also adds a costly feedback cycle, often involving

ev

multiple iterations, with the clinical investigational site. Batch data cleaning also suffers from
variability in implementation, including number and type of checks programmed, type of data

ie

checked, and number of iterations with sites. For these reasons, registries and quality

w

improvement reporting do not routinely use batch data cleaning, and the costs of batch data
cleaning (cited at $35–$100 per discrepancy for paper-based trials [139-141]), has led to their
utility being questioned in the context of multicenter clinical trials [141].

Relative accuracy differences between methods
The amount of overlap in the quality levels across data processing methods suggests that
different data processing methods or combinations thereof can achieve comparable accuracy.
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Data cleaning methods that are applied during or after data entry, while creating additional costs
and user burdens, are likely to increase the accuracy obtainable from a data entry method. For
example, use of OSCs was associated with lower error rates and lower variability, whether data
were entered at clinical sites or at a central data center. Additionally, distributed data entry with
OSCs was associated with error rates similar to those obtained from double-entered data. This
could be attributed to the proximity to source information where data are entered at clinical
investigational sites. The latter two comparisons are critical, because adoption of Web-based

Fo

EDC necessitates single data entry at clinical investigational sites. The information presented

rP

here should prompt those using EDC to fully utilize OSCs.
Perception of acceptability regarding different error rates varies from “10% is good” to “1%

ee

is good” to “there should be no errors [6,20,38].” The answer to the question, “How clean is
clean enough?” is multifaceted. The effect of errors is dependent on the variable in which the

rR

errors occur, the number and extent of the errors, and the robustness of the analytical method

ev

[43]. Based on simulations showing an approximate reduction in statistical power of 1% for each
additional percent of the error rate [23,41,42] and the analytical work of Rostami et al [40], the

ie

abstraction error rates seen in the published literature are high enough to impact upon the

w

decisions made using the data. Abstraction is a crucial method of data collection, and will remain
so until data in the healthcare setting are sufficiently standardized to support automated
extraction from EMRs. Until that time, data will continue to be manually extracted from both
paper and electronic records. The association of abstraction with high error rates and significant
variability, as noted here, supports recommendations that both abstraction methods and measures
of accuracy should be reported with the results from studies employing medical record
abstraction [126,127].
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Limitations
This study is a secondary pooled analysis of database error rates in the published literature.
Although it constitutes a critical contribution in synthesizing a very fragmented literature base,
there are many limitations inherent in our work. First, there is the possibility that we may have
missed relevant articles. Second, because our work is a secondary analysis, it relies on data that
were collected for other purposes. Although we used error and field counts reported in the

Fo

literature, prior work has shown that even these have significant variability [37,38]. For example,

rP

some may count dates as discrepant if there is not an exact match, while others may allow a
window of several days; field counts may exclude null fields, or include fields entered once and

ee

propagated to multiple places. Results presented here should be examined in this context. Third,
a lack of standard terminology for data processing methods potentially affects this analysis

rR

through high likelihood that relevant manuscripts were not identified as mentioned above, and

ev

also through misinterpreting the information presented in the source manuscripts. Fourth, due to
the small number of data points in some subgroups, comparisons between data cleaning methods

ie

are less reliable than for the four higher-level categories of data processing methods. Fifth, some

w

of the articles we included in our analysis reported an assessment of only a few variables, while
others analyzed many variables or an entire database. Given the observed variability in data
quality for different therapeutic areas, likely driven by the differences in the type of data, reports
of error rates on only 1 or a limited number of variables are less generalizable. Sixth, most of the
articles in our review were from academic organizations and government or foundation-funded
endeavors that employ different data collection and management methodologies. Although over
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the time span of the literature we reviewed, those methods have tended to converge, our results
may be less applicable to industry funded studies.
Given these limitations, we draw conclusions only about associations and trends.
Importantly, although there is strong correlation between data processing method and both
central tendency and dispersion of data error rates, this association does not imply causality, and
other important factors not assessable here may be responsible for these results. Other possible
explanations for the variability seen here include variations in local system implementations and

Fo

workflows, the number of data processing steps, differences in reporting error rates, skill level of

rP

the staff, and complexity of the data. These factors were not assessable in a literature review such
as ours. The inability to measure or control for these possible alternatives represents a weakness

ee

in this analysis, and they remain topics for further investigation.

rR

Further research

ev

The published information on data quality derives mainly from evaluation and observation of
data accuracy in funded registries and clinical trials, as opposed to targeted experimental inquiry.

ie

While a biannual conference on cross-industry data quality exists [142], and a clinical research-

w

focused Data Quality Research Institute was founded in 2004 [143], funding for dedicated data
quality research has remained slim or non-existent; therefore, there are few controlled
experiments evaluating data capture or cleaning methods to date and even less generalizable
work contributing to the body of knowledge. Research from multiple epistemological stances
would provide valuable information to confirm or challenge the trends identified here. Further,
as data (increasingly captured electronically) are used to support direct patient care, performance
measurement, and research, the effects of data quality on decision-making need thorough
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exploration, as do the effects of system usability and data entry and cleaning methods on data
quality and clinical workflow.

Conclusions
The formal literature on clinical research data quality remains significantly fragmented.
Standardizing terminology and using it to index the literature base may lead to wider recognition
of the applicability of data quality work within clinical research and biomedical informatics and

Fo

provide amalgamation points. Importantly, the results presented here, while gained from a

rP

secondary analysis, are of immediate use in informing investigators and research teams of the
options and characterization of common data collection and processing methods with respect to

ee

data accuracy. In particular, the variability if not the magnitude of error rates reported should
encourage evaluation of the impact of new technology and processes on data accuracy, and

rR

subsequent decisions regarding whether the accuracy is acceptable for the data’s intended use.

ev

In synthesis, we suggest that data quality varies widely by data processing method. Further, it
appears that the lowest-quality process, abstraction, is the most ubiquitous and also the least

ie

measured and controlled within research projects. Although they pale in comparison to

w

abstraction error rates as a source of variability, the differences in accuracy of data entry methods
also deserve consideration. On average, double data entry provides the highest accuracy and
lowest variability, followed by single entry. Of all popular data entry techniques, optical methods
provide the lowest data quality and the highest variability. However, other confounding factors
assessed, including use of OSC with single data entry, and batch data cleaning checks, as well as
factors not identifiable or assessable in a secondary analysis (e.g., staff experience, number of
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manual steps, and data complexity), may constitute substantial mediators with the potential to
equalize differences between methods.
Error rates reported in the literature are well within ranges that could necessitate increases in
sample sizes from 20% or more in order to preserve statistical power for a given study design
[144,145]. Data errors have also been shown to change p values [44] and attenuate correlation
coefficients to the null hypothesis [42,146,147]; in other words, a given clinical trial may fail to
reject the null hypothesis because of data errors rather than because of a genuine lack of effect

Fo

for the experimental therapy [149]. In the presence of large data error rates, a researcher must

rP

then choose to either 1) accept unquantifiable loss of statistical power and risk failure to reject
the null hypothesis due to data error; or 2) measure the error rate and increase the sample size to

ee

maintain the original desired power [40,145,147]. The adverse impact of data errors has also
been demonstrated in registries and performance measurements [121,149-154], as has failure to

rR

report data [155].

ev

While such results in aggregate are shocking, we do not present them to incite panic or cast
doubt upon clinical research results. Other factors that are not assessable here, such as variables

ie

in which the errors occurred, and statistical methods used to take the measurement error into

w

account, are necessary for such assessments. We applaud the authors of the reviewed papers for
their rigor and forthrightness in assessing error; measurement is the first step in management. We
hope that our analysis makes a strong and convincing argument for the measurement and
publication of data accuracy in clinical research.
While there is general agreement that the validity of research rests on a foundation of data,
data collection and processing are sometimes perceived as menial and peripheral to the core
operations of caring for patients or completing a clinical research project. In between rote data
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entry and scientific validity, however, lie many unanswered questions, which, if answered, will
help investigators and research teams balance cost, time and quality while assuring scientific
validity.
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Figure legends
Figure 1 Chronology of the database error rate literature.
Figure 2 Data error rates for data processing methods. Error rates, medians and 95% confidence
intervals are displayed with a logarithmic axis. The medical record abstraction process is
associated with the largest and most variable error rate. Similarly, optical methods, such as
optical mark recognition (OMR) and optical character recognition (OCR) as well as single data
entry show variability that spans more than one order of magnitude.

Fo

Figure 3 Subgroup analysis for single entry. Error rates, medians and 95% confidence intervals

rP

for cases reporting single entry. The impact of location of data processing and the impact of onscreen (i.e., at the point of entry) error checking were examined. Location had little effect on data

ee

accuracy, while presence of on-screen error checks was consistently associated with a decreased
error rate.

rR

Figure 4 Error rates for single-entered data in the presence of on-screen error checks. Figure 4

ev

displays error rates, medians and 95% confidence intervals for single-entered data in the
presence of on-screen error checks. This combination most closely resembles today’s Web-based

ie

EDC process and shows that the EDC model is likely capable of producing data of comparable

w

data processing accuracy to paper-based methods.

Figure 5 Subgroup analysis for batch data cleaning. Error rates, medians and the 95%
confidence intervals from the sub-group analysis for batch data cleaning are displayed. As
expected, batch data cleaning was associated with a lower error rate. In addition, the upper mode
of the batch cleaned data consisted of medical record abstraction studies, showing that in-house
batch data cleaning is most likely not capable of identifying and correcting errors created in the
medical record abstraction process.
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Table 1 Sources of articles
Journal

Number of
Articles

Controlled Clinical Trials/Clinical Trials Journal

17

American Journal of Epidemiology

4

Journal of Clinical Epidemiology

3

Journal of the American Medical Informatics Association (AMIA) or AMIA

3

Proceedings
International Journal of Epidemiology

2

International Journal of Quality in Healthcare

2

European Journal of Cancer

2

Journal of Clinical Oncology

2

Scandinavian Journal of the Society of Medicine

2

Journal of Trauma Infection and Critical Care

2

Pediatrics

2

rP

2

ee

Fo

Computers in Biomedical Research

48

Total

93

w
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ev

rR

Various medical specialty and informatics journals contributing one article
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Table 2 Categorization of articles used in this review
Literature Categorized by Type of Secondary Use and Data Processing Method
Reports of operational accuracy assessments to determine the usability of administrative
databases for research or surveillance [45-50]
Reports of database quality control in clinical trials where gold standard was the medical record
[12,15,20,24,51-56]
Reports of quality control in epidemiological, survey or observational studies where the gold
standard was the medical record or taped interview [46,57,62]
Reports of instrument validation studies where the gold standard was the medical record or

Fo

patient self report [63,64]

Reports of database quality control in research or quality improvement registries where gold
standard was the medical record [13,50,57,65-78]

rP

Reports of stand alone data processing studies using clinical trial-type forms and processing
[11,33,64,79,80]

ee

Reports of medical record abstraction evaluation [12,56,77,80,81]
Reports of clinical trial data processing quality that used the Case Report Form or other data
10,22,25,41,59,79,82-96]

rR

processing step as the gold standard in a comparison to the trial database [7Reports of database quality control in surveillance registries [48,49,94,97-120]
[32,47,94,121,122]

w

ie

ev

Reports of data accuracy assessments of other health-related primary or secondary data uses
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Table 3 Data processing dimensions
Processing dimension

Description

Location of data processing

Whether data were entered and cleaned at a central
data center or a local healthcare facility

Central coordinating center

Data center receiving and processing data from
multiple sites. A healthcare facility does not qualify
as a data center.

Local research site or healthcare

Location or institution where data were collected

facility
Single

Method used to convert data to electronic format
One person enters data once
Two different individuals enter data. Distinction was

rP

Double

Fo

Type of entry

entry.

Data on paper forms were optically scanned into

ee

Optical mark/character recognition

not made between different types of double data

electronic format

entered

Physical representation (if any) that the data enterer

rR

Source from which data were

looked at during data entry

Medical record (paper chart)

Paper documentation of patient care produced and

ev

maintained by a healthcare facility

Electronic medical record

Electronic documentation of patient care produced

ie

and maintained by a healthcare facility
Paper data collection form

Structured data collection form completed by

w

healthcare or research staff
Live interview or ePRO

Patient recall and direct electronic report

Image displayed on computer

Electronic representation of a data collection form

screen

rendered on a computer screen

Type of error checking*

Method, if any, used to clean data

On-screen during data entry

Real-time error checks that run during data entry

Post-entry batch computerized

Computerized error checks run after data entry,

checks
Visual verification

usually nightly
Manual comparison of entered data to the entry
source
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Table 4 Dimensions of data quality assessment
Process being measured
Source to database: process from medical record to database, including abstraction, data
entry, and cleaning.
Source to data collection form: abstraction process from medical record to data collection
form. Does not include data entry and cleaning.
Data collection form to database: process includes data entry and cleaning.
Single entry: only process measured is one entry of data.
Type of database assessed

Fo

Healthcare administrative database: coded data intended for use in billing.
Registry database: secondary database including phase 4 trials, surveillance programs,

rP

quality improvement and disease registries.
Trial database: secondary dataset collected for a clinical trial.
Case report form or data collection form: structured data collection form; secondary data.
computer.
Method of Measurement

rR

ee

Computer aided interview / Patient self report: dataset containing patient reported data via a

Comparison to a “gold standard”: manual comparison of two datasets from different sources or
two different points in a process.

ev

Independently re-processing data: data processed from the same source by an independent
individual.

“Gold Standard” for comparison

w

ie

Linking and comparing data electronically: electronic comparison of two separate databases.

Medical record (paper or electronic): paper or electronic documentation of care produced and
maintained by a healthcare facility.

Independent or taped patient self-report: patient recall and direct electronic report.
Data collection form: structured data collection form completed by healthcare or research staff.
Independent database: database created from a separate source.
Data Independently entered from same source
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Table 5. Descriptive statistics by data processing method
Median

Mean

SD

Min

Max

Abstraction

647

960

1018

70

5019

Optical

81

219

337

2

1106

Single Entry

26

76

150

3.8

650

Double entry

15

16

10

3.5

33

SD = standard deviation
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Table 6a Descriptive Statistics for Single Entry Subgroup Analysis
Mean Median

SD

Min Max

Central

77

30

143

4

650

Distributed

86

25

175

15

550

Distributed, no on-screen checks

550

550

*

550

550

Distributed, On-screen Checks

28

24

17

15

69

All no on-screen checks

158

52

211

4

650

All with on-screen checks

23

22

15

4

69

*There was only one value for distributed single entry with no on-screen checks
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SD = standard deviation

Table 6b Descriptive statistics for central versus distributed data processing

rP

in the subset of articles reporting use of on-screen checks
Mean

Median

19

17

Distributed

28

24

Max

12

4

39

17

15

69
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SD = standard deviation

Min

ee

Central

SD
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Table 7 Descriptive statistics for batch subgroup analysis
Mean

Median

SD

Min

Max

648

270

946

2

5019

306

36

428

2

1351

No batch data cleaning
reported
Batch data cleaning reported
SD = standard deviation
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Defining Data Quality for Clinical Research:
A Concept Analysis
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Despite notable previous attempts by experts to define data quality, the concept remains
ambiguous and subject to the vagaries of natural language. This current lack of clarity continues
to hamper research related to data quality issues. We present a formal concept analysis of data
quality, which builds on and synthesizes previously published work. We further posit that
discipline-level specificity may be required to achieve the desired definitional clarity. To this
end, we combine work from the clinical research domain with findings from the general data
quality literature to produce a discipline-specific definition and operationalization for data
quality in clinical research. While the results are helpful to clinical research, the methodology of
concept analysis may be useful in other fields to clarify data quality attributes and to achieve
operational definitions.
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1. INTRODUCTION
The most common definition for quality, including data quality, is “fitness for use” [Batini and
Scannapieco 2006; Lee, Pipino, Funk and Y. 2006]. This broad definition abstracts across
differences among industries and focuses attention on the customer; both attributes are
beneficial. However, the corresponding lack of definitional specificity precludes use in research,
as well as operationalization within specific disciplines. Citing Juran’s “fitness for use”
definition, the American Society for Quality acknowledges both high-level and discipline-

Fo

specific needs and defines quality as “a subjective term for which each person or sector has its

rR

own definition” [Quality Progress Editorial Staff 2008]. This formulation implies that employing
a more abstract definition without refining its application within the specific discipline of data

ev

quality could have detrimental effects.

Successful theoretical development requires well-defined concepts. It is incumbent upon

ie

researchers within disciplines to define concepts with specificity capable of supporting scientific

w

inquiry in the context of overarching theory. The purpose of this work is to clarify the term

On

clinical research data quality for use in theory development, research, and application to
operations. Simply put, we cannot test a poorly defined theory, nor manage what we cannot

ly

measure [Redman 1996].

2. BACKGROUND
2.1.

Clouding Factors

There is ample reason for the fuzziness that has historically surrounded the concept of data
quality. Most authors define data quality as a multidimensional concept with dimensions that
include categories such as accuracy, currency, consistency, and completeness [Batini et al. 2004;
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Batini and Scannapieco 2006; Pipino et al. 2002; Redman 1996; Tayi and Ballou 1998; Wand
and Wang 1996; Wang and Strong 1996]. This multidimensionality (multiple attributes),
however, can lead to ambiguity and imprecision because different groups may emphasize some
dimensions while excluding others.
For example, the information technology (IT) sector defines data quality by conformity to
data definition and stated business rules, while regulatory and legal groups tend to emphasize
attribution and verifiability [U.S. Food and Drug Administration 2007]. It is likely that in many

Fo

contexts only a subset of attributes will be considered important; thus, proliferation of use-related

rR

and use-specific definitional subsets will continue. Further complicating matters, data quality has
dimensions that are inherent to the data, such as accuracy, and dimensions that are context

ev

dependent, such as timeliness and relevance [Lee et al. 2002; Wand and Wang 1996]. Moreover,
even inherent characteristics may be relative; i.e., what constitutes good quality for some uses

ie

may be poor quality for others [Ge and Helfert 2007; Wand and Wang 1996].

w

Additional confusion exists between data quality and related concepts. For example,

On

inherent characteristics of data (e.g., volatility and accessibility) have been used as dimensions of
data quality. Likewise, attributes of the systems used to store and provide access to data are

ly

sometimes referred to as data quality dimensions, obscuring the distinction between data and
system [Redman 1996]. For example, suboptimal system usability, implementation choices, or
data structure may be construed as data quality issues.

2.2.

Prior Attempts to Clarify the Concept of Data Quality

In spite of the efforts of experts in the field, the concept of data quality remains elusive. Some
texts do not define data quality [Liepins and Uppuluri 1990; Maydanchik 2007; Naus 1975],
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while other works adopt the generic (and abstract) “fitness for use” definition [Herzog et al.
2007; Olson 2003; Redman 1996; Redman 2001]. Lee and colleagues [2006] state that data
quality should be defined in the context of the organization, using applicable dimensions from
the literature, but they do not provide examples. Still others provide multiple definitions, or
simply note that there “is no general agreement either on which set of dimensions defines data
quality or on the exact meaning of each dimension” [Batini, Catarci and Scannapieco 2004].
Quality dimensions are similarly diverse and have been classified into three broad

Fo

categories: 1) intuitive approach; 2) empirical approach; and 3) theory-based approach [Batini,

rR

Catarci and Scannapieco 2004], with each category ranked according to number of citations
[Wand and Wang 1996]. The association of the same term to different definitions characterized

ev

by Batini [2006] indicates that progress toward a consensus dimension-based definition is still
hindered by vagaries of natural language and idiosyncratic usage. Importantly, with the

ie

exception of Orr’s System Theory work, Wand and Wang’s ontological work, and Frank’s

w

ontological work specific to the geospatial mapping domain [Frank 2007; Orr 1998; Wand and

On

Wang 1996], the concept of data quality has not been linked to theory.
Where specificity can not be obtained for an entire field (as in the case of data quality), it

ly

may be possible within a specific sector [Batini and Scannapieco 2006; Quality Progress
Editorial Staff 2008]. Accordingly, we sought to achieve a discipline-specific definition and
attribute list for clinical research data quality that accommodates the context of broader data
quality work.
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2.3

Needs of Clinical Research

Research data management is an exercise in mass customization [Koh 2008]. A clinical trial
database is considered a product; the customers are the statisticians analyzing the data and the
clinical community interpreting the results. The data collected and the level of quality
appropriate for each variable both depend on the scientific question(s) being asked and the
statistical tests applied in each study—one study’s major independent and dependent variables
and important covariates might be only background supporting data for another study.

Fo

Necessary data quality also depends not only on which variable/s are in error, but also on the

rR

degree of robustness of the statistical analysis to those errors [Nahm et al. 2008].
Because the development of clinical knowledge often entails combining data from

ev

different studies, or from studies managed by different organizations, a consistent definition of
data quality and standard ways of measuring it are critical [Nahm et al. 2004]. As these needs are

ie

discipline-specific, a correspondingly specific definition for clinical research data quality may be

w

appropriate. Such a definition, however, should remain compatible with the context of the

ly

On

research done in the broader data quality domain.

3. METHODS

We performed a systematic concept analysis using the method of Walker and Avant, in which a
concept is clarified through explication of antecedents, consequences, attributes, and cases
[Walker and Avant 2005]. Due to the richness of work in data and information quality and our
desire to preserve that broader context, we approached our project as a concept derivation rather
than a de novo concept synthesis [Walker and Avant 2005]. Although clinical research data
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quality shares dimensions with the more generic term used in IT and data warehousing, the
importance and definition of the dimensions differ, as does the unit for decision-making.
Following Walker and Avant, attributes (called dimensions in the data quality literature),
were identified through a review of the general data quality literature that used the Google
Scholar™ search engine to identify relevant articles. Due to the large number of results retrieved
(218,000 citations for “data quality” and 43,800 citations for “data quality” AND “theory”), we
focused on review papers and published books. Attributes from the literature applicable to

Fo

clinical research were selected and categorized. Where possible, literature definitions were used,

rR

although in some cases there were significant conflicts in definitions across various sources
[Batini and Scannapieco 2006].

ev

3.1.

Uses of the Data Quality Concept

ie

While business, IT, and manufacturing sectors tend to favor the “fitness for use” definition of

w

data quality, the term has been used in clinical research to denote accuracy of the data; i.e., the

On

extent to which the data reflect the true state of the patient. The Institute of Medicine defines
quality data as those that “support the same conclusions as error-free data” [Institute of Medicine

ly

1999]. In previous work, Nahm et al. applied the label data quality to what was in fact a measure
of data accuracy [Nahm, Pieper and Cunningham 2008]. To a greater extreme throughout the
clinical research industry, the result of a data quality assessment refers to a narrow scope, such as
fidelity of data processing or compliance in measuring, observing, or collecting data [SCDM
2007]. In clinical registries, data quality refers to a subset of dimensions, most commonly
accuracy and completeness [Arts et al. 2002]. In IT, data quality incorporates conformity to
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syntactic constraints, as well as accuracy and completeness [Herzog, Scheuren and Winkler
2007; Naus 1975].
The term quality itself is problematic. Merriam-Webster’s Dictionary lists eight
definitions for quality (Figure 1), aspects of which are to be found in technical usage (e.g.,
degree of excellence; inherent feature; distinguishing attribute). Similarly, the definition of data
remains a topic of academic debate [Johnson 2008]. One school of thought posits data as a
difference (for example, a black dot on a white page constitutes data), and that data plus meaning

Fo

create information [Floridi 2008]. Coiera, [2003] on the other hand, considers data the raw form

rR

of information.

[Figure 1. Caption set underneath illustration.]

data (Figure 2).

ie

ev

As with the term quality, these differing definitions and interpretations cloud the term

[Figure 2. Caption set underneath illustration.]

w

For example, if we adopt the first Merriam-Webster’s definition (factual information), the output
of aggregate reports would constitute data, and thus the concept of data quality should apply at

On

the aggregate level. Others, adopting a Floridian or Coieraian interpretation, likely would not

ly

apply the concept of data quality to an aggregate report. Additionally, meaning is a pivotal point
between the Coieraian and Floridian definitions. One possible attribute of data quality is
specificity (non-ambiguity), which requires meaning to accompany data, and implies that it is not
data quality that we should be concerned with at all, but rather information quality.
Definitional work to date has not yielded the clarity needed for theoretical development
and research. Because scientific and operational use of a concept requires focus and precision,
this work proceeds with the scientific and operational uses of the term data quality.

An ACM Publication

Journal of Data and Information Quality

Data Quality Concept Analysis
3.2.

Antecedents and Consequences

Data quality has a number of necessary precursors. First, there must be data, as defined by
Floridi [2008] or Coiera [2003]. Second, data must possess attributes sufficient for us to
recognize them as the particular data of interest. Interestingly, the more we know about data, the
more they approach the Floridian definition of information; thus, the difference between data
quality and information quality, if one exists, is not illuminated by this analysis. Third, there
must be a representation of data such that humans or machines can recognize and process them.

Fo

Fourth, there must be a source for comparison so that the quality or dimension of data quality can

rR

be judged (i.e., a concept of truth, correct value, or reference point).
The ultimate consequence of data quality in the Juran sense is that the data are fit for the

ev

customer’s use. In clinical research, data that possess quality “support the same conclusions as
error [blemish] free data” [Institute of Medicine 1999]. (The term blemish was added to account

ie

for the dimensions in addition to accuracy that effect data use and usefulness.) Importantly,

w

Juran’s “fitness for use” definition is broader than the IOM’s. In clinical trials, when a

IOM definition.

ly

3.3.

On

statistician decides whether available data can be used for an analysis, he or she is applying the

Dimensions

Data quality dimensions are data characteristics that affect use and usefulness; further, they are
the mechanism through which we design, control, and increase data quality [Tayi and Ballout
1998]. The dimensions deemed necessary for clinical research—accuracy, currency,
completeness, consistency, timeliness, relevance, granularity, specificity (non-ambiguity), for
precision, and attribution were chosen from the literature (Table I) and used whenever possible.
[Table I. Table head on top of table.]
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Where literature definitions did not provide an adequate fit with clinical research use, disciplinespecific definitions were created. Also provided in Table I are operational definitions or metrics
for definitions.
Of note, defining dimensions at the level of measurable metrics helped clarify a
confounding factor characteristic of clinical research: while some dimensions may be assessed at
the data value level (e.g., correct vs. incorrect); in clinical research, decision-making occurs at
the database level (i.e., “Is this database of adequate quality to support the analysis?”). This

Fo

database-level information is derived by aggregating value-level results (for example, number of

rR

errors divided by number of data values) and differs from the broader data quality methodology
of value-level assessment and decisions.

ev

As with the broader data quality field, clinical research requires both inherent and
context-sensitive dimensions; for example, “timeliness” for expedited safety event data differs

ie

from the “timeliness” of database lock. We accommodated this issue by providing an operational

w

definition or measure, while leaving the acceptance criterion context-specific. In the case of our

On

example, “timeliness” is operationally defined as the difference between the date the data are
needed and the date they are available. The acceptance criterion (i.e., the definition of

ly

“excessively late”) is left to the customer. To clarify these different dimensions, Table I labels
each dimension as inherent or context-sensitive and provides a context-sensitive operational
definition.
Importantly, while inherent dimensions can be defined and assessed independently of
context, operational definitions for context-sensitive dimensions depend upon the intended use.
Thus, inherent dimensions can be stored as value-level or dataset-level metadata (i.e., with data,
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as advocated in several texts), whereas context-sensitive attributes by definition must be assessed
at time of use [Batini and Scannapieco 2006; Lee, Pipino, Funk and Y. 2006].
This approach differs significantly from others in that the assessment, although counted
on a data value-level basis, does not provide a data value-level metric for each dimension that
can be stored with each data value. In clinical research, data quality is defined based on these ten
dimensions as “dimensional metrics meeting the acceptance criteria of the data user and
consumer.”

Illustrating Cases

3.4.1 Ideal Case

rR

Fo

3.4

ev

A directory of research projects that contains descriptive information about each project was
created as a searchable inventory to aid in identifying scientific collaborations. A researcher

ie

seeking potential collaborators for a cell therapy study queries the database and retrieves three

w

projects. Two of the projects are hers, and she recognizes that the information is accurate,

On

consistent, and complete. She also notes that her study coordinator has been maintaining the data
and that it is current. The third project belongs to another researcher, indicating a potential

ly

collaborator. In this case, the data were available when needed, were relevant to her question,
and provided a sufficient level of detail to answer her question; therefore, the data are of high
quality.

3.4.2 Contrary Case
A researcher uses data from a similar directory at another institution to find potential
collaborators for a cell therapy study. He queries the database and retrieves two projects, but
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immediately suspects the data are incomplete, inaccurate, and inconsistent because one of his
own projects is missing, and another is listed as belonging to the incorrect investigator. Upon
closer examination, he is unable to tell who entered the erroneous data or when it was last
updated. One of the two returned projects belonged to another researcher, pointing him toward a
potential collaborator. However, it was unclear whether the telephone number listed was for the
trial call center or the investigator. Not wanting to risk embarrassment, he decided not to attempt
contacting the potential collaborator. In this case, although data were relevant and at an

Fo

appropriate level of detail, they were inaccurate, unattributed, incomplete, and inconsistent, and

ev

3.4.3 Illegitimate Case

rR

therefore were not quality data.

A researcher completes an analysis of a project and provides two tables and a listing to a

ie

colleague, who glances at the tables and replies, “Wow, nice job. These look great. High quality

w

work!” This scenario is not a legitimate example of data quality, because no attributes were

On

assessed. The colleague merely examined the table format and not the contents, and used no
source of comparison for the assessment. In addition, aggregate numbers on a table are not

ly

always an indicator of data quality; they may be an indicator of programming quality.

3.4.4 Borderline Case
A researcher downloads transcripts from focus group meetings. After reading the information, he
determines that the questions used in the groups are not sufficiently relevant to his research
question and decides that he cannot use the data for his intended purpose. This is a borderline
case, because relevance is an attribute of data quality. However, it is context dependent, in that
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the same focus group data were relevant to the original research questions asked. Thus, data may
not be relevant or at the right detail level for a secondary use, but may have been so for their
initial use.

4.0

CONCLUSION

We have advanced a definition for data quality in clinical research that includes the following
key attributes: accuracy, completeness, currency, consistency, timeliness, relevance, granularity,

Fo

specificity, precision, and attribution meeting the acceptance criterion of the data user and

rR

consumer. Clarity has been added through explication, differentiation, and definition. This clarity
was achieved at the expense of generality of application. An operationalizable definition for

ev

clinical research is a significant contribution, given its potential for supporting related research.
We were able to use general concept analysis techniques to achieve the desired clarity regarding

ie

the concept of data quality in clinical research. This analysis, while subject to the same

w

limitations of natural language that underlie the original ambiguities, delineates differentiating

On

and orthogonal characteristics of data quality attributes (e.g., inherent versus context-sensitive,
that enable operational definitions. Thus, while the results are helpful to clinical research, the

ly

methodology of concept analysis may be useful in other fields to clarify data quality attributes
and to achieve operational definitions.
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Figure Legends
Figure 1. Definitions of Quality. From: Merriam-Webster Online Dictionary, 2008 (used with
permission).
Figure 2. Definitions of Data. From: Merriam-Webster’s Online Dictionary, 2008 (used with
permission).
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Table 1. Data Quality Dimensions for Clinical Research
Accuracy

Inherent
Yes

Context
sensitive
No

Currency

Yes

Completeness

Yes

Operational Definition / Metric
Number of errors divided by
number of fields inspected
(implies comparison with a
gold standard)

No

The length of storage for a data
value (since last update)

Date of use/need minus date
data last updated

No

The extent to which every
represented real world state is
reflected in the data

Number of missing values
divided by number of fields
assessed

Where there are multiple
representations of real world
states in the data, they are the
same. For clinical research,
extended to: data values
representing the same realworld state are not in conflict

Number of discrepant values
divided by number of values
subject to data consistency
checks

Fo

Consistency
(internal)

Natural Language Definition
States in the data match the
intended state in the real
world (data values represent
real world truthfully)

Yes

No

Length of time from a change in
the real world state to the time
when the data reflect the
change

Date data are needed minus
date data are ready for
intended use

Relevance

No

Yes

Data can be used to answer a
particular question

Percentage of data values
applicable to intended use

Granularity

No

Yes

Level of detail captured in data

Percentage of values at level of
detail appropriate for intended
use

Specificity
(nonambiguity)

Yes

No

Each state in the data definition
(metadata) corresponds to
one (or none) state of the real
world

Number of values with full ISO
11179 metadata, including
definition, divided by number
assessed

Precision

No

Yes

Number of significant digits to
which a continuous value was
measured (and recorded); for
categorical variables, the
resolution of the categories

Percentage of values with
precision appropriate for
intended use

Attributability

Yes

No

Source and individual who
generates and updates data
are inextricably linked to data
values

Percentage of data values
linked to source and user ID
of person who generated and
changed the record

w

Yes

ie

No

ev

rR
Timeliness

ly

On

Italicized wording quoted from Wand and Wang 1996.
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Figure 1. Definitions of Quality. From: Merriam-Webster Online Dictionary, 2008 (used
with permission).
Figure 1: Definitions of Quality
1 a: peculiar and essential character : NATURE <her
ethereal quality> b: an inherent feature : PROPERTY
<had a quality of stridence, dissonance> c: CAPACITY ,
ROLE <in the quality of reader and companion>
2 a: degree of excellence : GRADE <the quality of
competing air service> b: superiority in kind
<merchandise of quality>
3 a: social status : RANK b: ARISTOCRACY

Fo

4 a: a distinguishing attribute : CHARACTERISTIC
<possesses many fine qualities> barchaic b : an
acquired skill : ACCOMPLISHMENT

rR

5: the character in a logical proposition of being
affirmative or negative
6: vividness of hue

ev

7 a: TIMBRE b: the identifying character of a vowel
sound determined chiefly by the resonance of the vocal
chambers in uttering it

ie

8: the attribute of an elementary sensation that makes it
fundamentally unlike any other sensation

w

--Merriam-Webster Online Dictionary
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Figure 2. Definitions of Data. From: Merriam-Webster’s Online Dictionary, 2008 (used
with permission).
Figure 2: Definitions of Data
1 : factual information (as measurements or
statistics) used as a basis for reasoning,
discussion, or calculation <the data is
plentiful and easily available>
<comprehensive data on economic growth
have been published>

Fo

2 : information output by a sensing device or
organ that includes both useful and
irrelevant or redundant information and must
be processed to be meaningful
3 : information in numerical form that can
be digitally transmitted or processed

rR

--Merriam-Webster Online Dictionary

w

ie
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Abstract
Medical record abstraction (MRA) is known to be a
significant source of data errors in secondary data
uses. Factors impacting the accuracy of abstracted
data are not reported consistently in the literature.
Two Delphi processes were conducted with
experienced medical record abstractors to assess
abstractor’s perceptions about the factors. The
Delphi process identified 9 factors that were not
found in the literature, and differed with the
literature by 5 factors in the top 25%. The Delphi
results refuted seven factors reported in the literature
as impacting the quality of abstracted data. The
results provide insight into and indicate content
validity of a significant number of the factors
reported in the literature. Further, the results
indicate general consistency between the perceptions
of clinical research medical record abstractors and
registry and quality improvement abstractors.
Introduction
As early as 1969, medical record abstraction was
associated with poorly described processes,
inconsistency and error1. By 1990, although many
advancements in data collection for research had
occurred, MRA was still regarded as problematic2.
While MRA remains a common method of data
collection for research and secondary data use3-6,
recent publications highlight the persistence of data
accuracy problems7, 8.
Importantly, MRA has been associated with the
highest and most variable error rates of common data
collection and processing methods8. These error rates
are high enough to cause problems in the use of
abstracted data8-11.
This study was conducted to characterize abstractor
perceptions about what factors impact the accuracy
of abstracted data. Research questions included: 1)
What factors do experienced abstractors think impact
the accuracy of abstracted data? 2) Does experience
as a clinical research or registry / quality
improvement abstractor create differences in
perception? 3) Do abstractor perceptions differ from

those factors most frequently mentioned in the
literature? If so, what are the differences?
Background
The literature contains several hundred articles about
medical record abstraction, however, existing work is
largely a-theoretical. Further, an authoritative
definition of MRA has not been articulated. The
following operational definition of MRA is used for
this research: A process in which a human manually
searches through a medical record to identify data
required for a secondary use. Abstraction involves
some direct matching of information found in the
record to the data required, but also includes
operations on the data such as categorizing, coding,
transforming, interpreting, summarizing, and
calculating. The abstraction process results in a
summary of information about a patient for a specific
secondary data use.
While at first blush, extraction of data directly from
electronic medical records may appear to be the
solution to accuracy issues in MRA, there are many
reasons why this is not likely the case12. Computer
programming resources, and sophisticated data query
tools, are currently required for such extraction.
These resources are not available to many
researchers, and few, if any, tools exist to automate
components of the abstraction process. Further,
barriers to accessing such resources may be high, and
for small investigator initiated studies, the costs
likely exceed those of manual abstraction. In these
cases, MRA will still be used and data accuracy from
MRA will remain a concern.
Methods
Two concurrent Delphi13 processes were conducted,
one with experienced clinical research abstractors
and one with experienced registry and quality
improvement abstractors to obtain from the expert
abstractors a list of factors that impact accuracy of
abstracted data.
Abstractors for the clinical research Delphi were
recruited at the Society for Clinical Research

76

Associates (SoCRA) national conference in
September 2009. Registry and quality improvement
abstractors were recruited at the American Health
Information Management Association (AHIMA)
National Convention in September 2009.

In Round 4 the participants were each provided an
individualized report of their Round 3 responses and
the aggregate of their Delphi. In all other aspects,
Round 4 was conducted in the same manner as
Round 3.

Eligible participants were individuals having:
1. Three or more years of abstraction
experience as reported by the participant
2. Abstraction experience in either a clinical
research or registry / quality improvement
setting
3. Able and willing to give informed consent

Rounds 1 and 2 were conducted using the cogix webbased survey system. Rounds 3 and 4 were
conducted via structured phone interview. To prevent
bias, an interviewer independent from the study team
was used.

In the first round, participants were asked to list from
five to ten factors that based on their experience,
impacted the accuracy of abstracted data. Following
Round 1, the factors were reviewed and sorted
according to semantic matches to obtain a list of
distinct factors and the number of times each was
mentioned.
The Round 1 factors were combined with factors
obtained from a systematic literature review and
provided back to the participants in Round 2. Factors
were presented as statements that each increased or
decreased the accuracy of abstracted data. In Round
2, the participants were asked to rate their level of
agreement with these statements on a five point likert
scale (strongly disagree, mildly disagree, neither
agree or disagree, mildly agree, and strongly agree).
Only participants who completed Round 2 were
eligible to participate in subsequent rounds.
In Round 3, the participants in each Delphi were each
provided an individualized report of their Round 2
responses versus the aggregate responses of their
Delphi. In Round 3, participants were 1) asked for
more information about factors where their response
was within one point* of the aggregate and factors
where their responses differed by more than one
point from the aggregate, and 2) given the
opportunity to change their responses should they
wish to do so. Requesting participants to tell the
interviewer more about their responses enabled
researchers to assure consistent understanding of the
statements on the Round 2 questionnaire as well as
provided the researchers more in depth information
about factors where there were disagreements, i.e.,
where answers depended on things external to the
statement such as differences in study types, or
clinical area.

*

One point was chosen because a difference of one point is
the difference between the categories on the likert scale.

Twenty clinical research abstractors and 18 registry
and quality improvement abstractors were consented
to participate in this research to retain at least seven
participants in the last round13. The participation rates
for the rounds are shown in Table 1.
Delphi Round
1

2

3*

4*

Clinical Research

80%

85%

68%

68%

Registry / QI

83%

67%

88%

88%

* denominator for Rounds 3 and 4 is the number of participants in
Round 2.

Table 1. Delphi Participation Rates
This research was reviewed and approved by the
Duke University and University of Texas
Institutional Review Boards.
Systematic Literature Review
To inform Round 2, a systematic review of the
literature was conducted to identify factors as
impacting the accuracy of abstracted data. A
PubMed query† in October of 2009 identified 361
articles. Abstracts for the 361 articles were reviewed
by two people resulting in the exclusion of 287. The
74 included articles were read in full by two
independent people. One hundred and thirteen new
articles and technical reports were identified from
citations in the reviewed articles, resulting in 187
articles reviewed. Of the 187 reviewed articles, 37
were subsequently found not to meet the inclusion
criterion, leaving 150 articles ultimately included in
the review. The inclusion criterion for this review
were that the articles had to be in the English
†

(((abstraction[Title/Abstract]) OR ("chart review"
[Title/Abstract])) OR ("medical record review"[Title/Abstract]))
AND ("clinical trial"[Title/Abstract] OR registry[Title/Abstract]
OR "clinical research"[Title/Abstract] OR quality[Title/Abstract]
OR "performance"[Title/Abstract]) AND (error[Title/Abstract] OR
accuracy[Title/Abstract] OR "data quality"[Title/Abstract] OR
errors[Title/Abstract] OR decision[Title/Abstract] OR
reliability[Title/Abstract] OR validity[Title/Abstract])
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language, describe use of healthcare data with the
medical record as the source, and mention at least
one factor in the accuracy of medical record
abstraction.
Each reviewer independently read each included
article and identified all statements of things that
impact (increase, decrease, or stated without valence)
accuracy of data abstracted from medical records.
Each reviewer was instructed to combine
semantically similar factors as such, e.g.,
reabstraction and independent re-review of charts
were counted as one factor rather than two distinct
factors. Factors stated at different levels of
granularity or with different modifiers or context,
e.g., reabstraction versus ongoing reabstraction were
retained as separate factors. Factors stated with
opposing valence were retained as distinct factors,
e.g., training abstractors increases accuracy versus
lack of training decreases accuracy. Independent
factor lists generated by each reader were compared
and disagreements were resolved through discussion.
This initial review identified 309 unique factors from
1063 instances of mentioned factors in the literature.
The list of distinct factors was used to categorize the
Delphi Round 1 results.
The factors were sorted by frequency of mention.
Seventy five (24%) of the literature factors had
greater than three mentions. These factors were
combined with the factors obtained from Round 1 of
the Delphi and were provided together to the
participants in Round 2. Factors from the literature
were injected into the Delphi process at Round 2
rather than Round 1 to prevent bias, e.g., participants
agreeing with stated factors rather than providing
factors most important from their experience. In
addition to standardized definitions, literature factors
were introduced to reduce variability that could arise
from different individual mental models of
abstraction, e.g., some individuals consider case
ascertainment as part of abstraction while others do
not. The number of factors from the literature used in
Round 2 was limited by the time allotted for the
rounds, because the informed consent stated that each
Round would take less than an hour.
Member checking occurred as part of the Delphi
design, i.e., participants see the aggregate results of
the previous Delphi round. A peer debriefing session
was conducted with 30 independent study
coordinators from Duke University Medical Center
in February 2010.

Round 1 Results
Round 1 of the Delphi returned 227 instances of
mentioned factors from which 94 distinct factors
receiving one or more mention were identified.
Twenty seven (29%) of the distinct factors received
greater than two mentions. Six mentioned items fell
outside of the working definition of Medical Record
Abstraction. Five mentioned items could not be
classified or otherwise labeled due to ambiguity of
the information provided by the participant. Nine
factors identified in Round 1 were not mentioned in
the literature at all (Table 2). Five factors were
mentioned in the literature, but were not in the top
24% (Table 3).
Factor

Number of
Mentions
10

Abstractor credentials
Access to charts

6

Interruptions

6

Complete and accurate medical record

4

Availability of abstraction tools

4

Adequate time for abstraction tasks

4

Complexity of the study or project

3

Supportive collegial relationships
with physicians, nurses, and
medical records colleagues

3

Abstractor (human) error

3

Table 2. Factors identified in Delphi Round 1 that
were Not Found in the Literature

Factor

Number of
Mentions
Delphi / Literature

Limited time

5/1

Lack of training

4/2

Same information found in
multiple places in the medical
record (opportunity for
conflicting information)

3/3

Incomplete review of the
medical record

3/1

Volume of information in the
medical record

3/1

Table 3. Factors identified in Delphi Round 1 Not in
the Literature top 24 %
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A total of 89 distinct factors (the top 29% of the
Round 1 responses and the top 24% of the literature
factors) were carried forward to Round 2. The top
29% and 24% correspond to > 2 and > 3 mentions
respectively. Including all mentions in each category,
i.e., all factors with >2 (Round 1) or >3 (literature)
mentions, caused the difference in percentages.
Three semantically redundant items were added to
test internal consistency, seven items were created
from existing factors containing multiple concepts;
99 items were used in Round 2 of the Delphis.

agree, 75 registry & quality improvement, 71 clinical
research. There were 3 factors with an overall rating
lower than neutral, all of these were between mildly
disagree and neutral. The registry and quality
improvement Delphi rated 7 factors lower than
neutral (Table 4). The clinical research Delphi rated
2 factors lower than neutral. All factors rated lower
than neutral originated from the literature.

Round 1 Discussion
Five of the factors not mentioned in the literature
were combinable with higher level factors or were
related to factors mentioned in the literature. For
example, abstractor credentials received 10 mentions
in the Delphi, while the literature contained mentions
for “necessity of a RN”, “presence of an advanced
degree”, and “certification of abstractors”14-17. For
this analysis factors at different levels of granularity
were not combined.
“Adequate time for abstraction tasks” mentioned in
the Delphi round 1, and “limited time” mentioned in
both the Delphi round 1 and the literature were not
combined. Likewise, “limited time” was not
combined with “lack of resources”. “Access to
charts” (Delphi Round 1), although related to
“missing charts” (Literature) was not combined due
to incomplete concept overlap and opposite valence.
Similarly, “complete and accurate medical record”
(Delphi Round 1) was not combined with “existing
error in the medical record” (Literature).
“Availability of abstraction tools” (Delphi Round 1)
was not combined with any of the numerous more
granular literature factors that mentioned different
types of abstraction tools, e.g., data collection form,
coding conventions, or data element definitions. The
afore mentioned five factors, while exhibiting
differences with factors reported in the literature are
not considered by the authors as new factors
identified through the Delphi.
While the literature mentioned several instances of
errors that the authors would classify as human error,
e.g., “abstractor overlooked values in the medical
record”, these instances were not classified to the
universal human error by the authors. Human error
and other factors considered by the authors as newly
identified by the Delphi are bolded in Table 2.
Delphi Results (all rounds)
Combining both Delphis, there were 73 factors with
overall average ratings between mildly and strongly

Factor

CR

R / QI

Overall

RN credential

3.2

2.2

2.8

Blinding abstractors to
study aims

2.5

1.9

2.2

Centralized
abstraction

3.2

2.7

3.0

High study / project
complexity

3.8

2.5

3.3

Thick medical records

3.2

2.8

3.1

Patients cared for by
multiple providers

3.6

2.8

3.4

Presence of multiple
diagnoses / procedures

2.8

2.6

2.7

Table 4. Factors Rated Lower Than Neutral
Discussion of Delphi Results (all rounds)
The two strongly refuted factors, “necessity of the
Registered Nurse credential”, and “blinding of
abstractors” were contentious in the literature. Some
argued for necessity of the RN credential due to the
associated knowledge of data flow and
documentation in the healthcare environment, ability
to locate information in the medical record, and
fluency in medical language6, 14-17. Others argued that
individuals with clinical knowledge were more apt to
interpret information in the medical record rather
than rigidly follow abstraction guidelines. Having the
RN credential strongly correlated with the perceived
necessity of the credential for MRA.
The literature was similarly conflicted regarding
blinding of abstractors. Some argued that blinding
abstractors to study endpoints prevented bias16, 18, 19.
Others argued that knowledge of the study purpose
and endpoints was necessary for abstractors to do a
good job7, 17, 20. This difference in opinion may be
due to different perceptions between investigators
versus abstractors, or different application areas, e.g.,
explicit versus implicit abstraction.
The low rating for presence of multiple diagnoses or
procedures is puzzling. This factor is cited by over 8
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articles in the clinical research, registry and quality
improvement literature as a factor impacting the
accuracy of abstracted data. The reported mechanism
is the difficulty assigning a primary diagnosis from
multiple possible problems. Further, two large and
robust studies in abstraction for billing conducted in
1977 by the IOM reported this as a major finding21,
22
. It is possible that this is no longer a factor, or that
while it may be a significant factor in claims
abstracting, it is not problematic in other areas.

4.

5.

6.

7.

Limitations
Homogeneity of participants is a critical factor in the
Delphi process. Our Delphi participants were
homogenous with respect to abstraction setting
(clinical research versus registry and quality
improvement) and experience level. However, there
is significant variation of practice within each setting.
Further, factors that may impact medical record
abstraction may vary across clinical area. Thus, these
results should be assessed in a particular practice area
rather than blindly applied. Additionally, over 200
factors mentioned in the literature, i.e., the bottom
76%, could not be evaluated in this research.
Conclusion

8.

9.

10.

11.

12.

From the consistency between the two Delphis, we
conclude that the factors impacting accuracy are
similar, i.e., differences between abstraction setting is
not itself among the largest of factors, and that best
practices and methods that improve accuracy in
abstraction for registries and quality improvement
projects may be applicable to clinical research.
From the number of factors and the high level (73%)
of agreement between expert abstractors and the
literature, we conclude that data accuracy in MRA is
a complex, many-faceted problem. Thus, solutions to
improving, controlling and assuring accuracy of
abstracted data will necessarily be multi-faceted.
The project received support from grant numbers
UL1RR024128 and UL1RR024148 to Duke Univ.
and Univ. of Texas Health Science Center Houston.
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Abstract
Medical record abstraction, a primary mode of data
collection in secondary data use, is associated with
high error rates. Distributed cognition in medical
record abstraction has not been studied as a possible
explanation for abstraction errors. We employed the
theory
of
distributed
representation
and
representational analysis to systematically evaluate
cognitive demands in medical record abstraction and
the extent of external cognitive support employed in a
sample of clinical research data collection forms.
We show that the cognitive load required for
abstraction in 61% of the sampled data elements was
high, exceedingly so in 9%. Further, the data
collection forms did not support external cognition
for the most complex data elements. High working
memory demands are a possible explanation for the
association of data errors with data elements
requiring abstractor interpretation, comparison,
mapping or calculation. The representational
analysis used here can be used to identify data
elements with high cognitive demands.
Introduction
Data collection in clinical research, both
retrospective and prospective, relies on the
abstraction of data from medical records1, 2.
Abstraction is a time and resource intensive task3, 4 and
is associated with high error rates5. However, little is
known about the causes and mitigators of these
errors6. Over time, authors have suggested that the
design of the data collection form is a significant
factor in the accuracy of abstracted data7, 8, 9, 10.
Although data collection forms are widely touted as a
key factor in data quality, little evaluative work has
been done to understand the mechanism and impact
of data collection form design on data accuracy.
Today, the design of data collection forms is guided
by primarily a-theoretical lists of things that form
designers should and should not do8, 15, 16.
While the role of paper-based patient records in
clinician cognition has been studied14, the extent to
which data collection forms impact cognition in
clinical research data collection has not yet been

investigated. Furthermore, cognitive science models
and methodology have yet to be applied to medical
record abstraction in clinical research or other
secondary data use settings.
From cognitive science we know that distribution of
information
across
internal
and
external
representations, i.e., in the user’s mind and in the
world,
affects
human
task
performance13.
Additionally, representation can extend human
performance through external cognition12, 13. Thus,
data collection forms may impact data accuracy
through form representation that supports distributed,
i.e., external cognition, and through the number and
extent of mental steps between the data source and
the collection form.
We applied the distributed cognition framework12 and
adapted Gong’s information search model11 to
medical record abstraction, and applied them through
a representational analysis to perform a systematic
evaluation of paper data collection forms to 1)
identify the type and extent of internal cognition
required in medical record abstraction, and 2) to
characterize the extent of support for external
cognition in data collection forms.
Background
Medical record abstraction entails the identification
of required data in the medical record,
transformations of that data, and recording the data
onto
data
collection
forms.
While
two
representations, 1) the source medical record, and 2)
the destination data collection form, may impact data
accuracy, secondary data users usually cannot impact
how data are represented in the medical record.
However, secondary users can control the
representation of their data collection forms, e.g.,
data collection forms often employ form instructions,
prompts, and structural or graphical elements to
guide form completion8, 15, 16. However, the presence
of these elements, their extent and format are
inconsistent on data collection forms 15. Since data
collection forms are present during the abstraction,
and within control of the secondary data users, there
is reason to believe that they may provide a
mechanism to decrease cognitive load by increasing
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support for external cognition during the abstraction
process.
In his 2006 work, Gong applied the theory of
distributed representation to explore how information
distribution between internal and external
representations
affects
information
search
performance11. He demonstrated that search task
performance improved with increasing amounts of
information represented externally11. Further, this and
other work, has shown that search task performance
improves when the scales17 between the task and the
data representation match11, 12.
Because medical record abstraction is both a search
and a cognitively intense process, the Gong model
has particular utility for exploring and characterizing
the extent to which data collection forms support
distributed cognition in medical record abstraction.
As such, we adapted Gong’s model to the task of
medical abstraction (Figure 1). Document boxes
were added for medical record and data collection
form representation. Task boxes were added for both
documentation and abstraction tasks. Remember,
transform, and transcribe are shown at the sub-task
level, clearly delineating them from the search subtask. In addition, localize from Gong’s model was
considered a direct search sub-task, while compare
and calculate were relocated to the transform subtask along with additional transformations interpret,
map, and scale conversion, i.e., a transformation
from one scale to another, e.g., ratio representation in
the medical record, and data collection form
representation as an ordinal category. Importantly, all

Represented
Information

Documentation
Task

tasks presented opportunities for distributed
cognition. Light grey boxes were added for
completeness but are not evaluated here.
In medical record abstraction, information is
represented both in the medical record and on the
data collection form.
Therefore, there are
opportunities for mismatch between 1) the
represented information and the representing medical
record, 2) the representing medical record and the
representing data collection form 3) the represented
information and the representing data collection
form. Moreover, the search, remember, transform,
and transcribe tasks are performed internally and
likely increase working memory load unless external
cognition artifacts exist.
While the medical record may have artifacts that
enable external cognition for search tasks, the
remember, transform, and transcribe tasks are unique
to each secondary data use. Therefore, we expect
that medical record representation will not provide
significant opportunities for external cognitive
support for these tasks. Thus, we evaluated paper
data collection form external cognition artifacts
rather than any particular medical record
representation.
In medical record abstraction, virtually every data
element by definition has a search task. Each data
element may or may not have form artifacts
supporting external cognition. Further, for each data
element, zero to multiple transform tasks may apply.
Each transform task required for a data element may
or may not have an external cognition artifact.
Medical
Record

Search Task

Abstraction
Task
Search Task

Remember Task

Remember Task

(declarative or procedural)

(declarative or procedural)

Transform Task

Transform Task

Transcribe Task

Transcribe Task

Documentation-related
Cognition

Abstraction-related
Cognition

Figure 1. Model of Cognition in Medical Record Abstraction

Data
Collection
Form
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Methods
Fifteen structured paper-based data collection form
modules* were randomly selected from the data
collection form library at the Duke Clinical Research
Institute. The library houses data collection forms,
many of which have been broken out by modules.
We sampled the 256 available modules, randomly
selecting 15 modules. Once nine unique trials were
obtained, the remaining five modules were accepted
sequentially only if they were from a trial already
selected for the sample. This allowed comparison
between forms within a trial.
The fifteen modules were from nine different clinical
trials completed from 1992-2004. The module types
and number of data elements per module are listed in
Table 1. In total, 250 data elements were assessed.
Module Type

Data
Elements*

Patient status (Trial 1)

25

Drug administration (Trial 1)

9

Canadian Cardiovascular Society Class (Trial 2)
Pacemaker mode change form (Trial 2)

4
32

Drug administration (Trial 3)

18

Platelet count (Trial 3)
Post procedure repeat catheterization (Trial 4)

12
18

Cardiac markers (Trial 5)
Clinical global impression (Trial 6)
Thyroid function tests (Trial 6)
Serum pregnancy test (Trial 6)
Medical history (Trial 7)
30 Day follow-up (Trial 8)
30 Day follow-up (Trial 9)
Cardiac enzymes (Trial 9)
* Only unique data elements were assessed and counted

26
6
12
6
14
48
11
9

Table 1. Characterization of Modules Selected for
this Study.
Ten of the analyzed modules reflected different data
content areas. Five of the analyzed modules were
different representations (isomorphs) of the same
content, e.g., lab results, from different forms
collected in different formats. The analysis of
multiple instances of similar module content allowed
assessment of differences in representation of similar
data elements.
For the representational analysis, each data element
was reviewed and classified by two independent
reviewers (informatics graduate students in a health
data display class) who were both novices to medical
*

A module is a section of a data collection form containing data
grouped by topicality, e.g., vital signs, physical exam, lab results.
Modules are usually, but not always less than a page.

record abstraction. Our unit of analysis was the data
element, i.e., a form question and the associated
response field† Each reviewer classified the
following eight aspects of each data element: Scale of
the represented information (nominal, ordinal,
interval, ratio), Data collection form representing
scale, Scale of the abstraction task, Presence of a
search task (yes, no), Presence of external
representation for the search task (yes, no), Type of
other transform tasks, if present (compare, calculate,
interpret, other), Enumeration of dimensions required
to abstract the data element, and whether the Rule
representation for the abstraction task and
transformations was (internal, external).
Briefly, a search task is the locating of a data value,
e.g., finding documentation of the gender of a subject
in the medical record. A transform task is a
manipulation or conversion of a data value, e.g.,
categorizing a specific medication according to class,
or converting units on a lab value or drug dose. The
rule is the logic that defines such a transformation.
For this analysis, scale conversions were counted
separately from other transformations.
A third person experienced in medical record
abstraction adjudicated the work of the two
independent reviewers; discrepancies were resolved
by the adjudicator and final data were reviewed by all
three reviewers.
We recognize that the representation in the medical
record likely impacts cognition during medical record
abstraction. However, we did not assess
representation in the medical record because 1)
medical record systems should optimize cognitive
support for care delivery and clinical documentation
rather than secondary data use, and 2) medical record
representation differs from institution to institution.
The impact of medical record representation on
accuracy of abstracted data remains an area for future
research. Similarly, abstractor experience may also
impact cognitive demands by obviating of the need
for transform through direct association, e.g., body
mass index of 47 equating to obese. Impact of
abstractor experience remains an area for future
research.
Results
Of the 250 data elements assessed, 98 (39%) were
direct transcription, i.e., once the value was located
in the medical record, it could be copied directly onto
the data collection form without transformation. For
example, a blood pressure value recorded in the
†

Data element is formally defined in ISO/IEC 11179-1.
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medical record in the same units as those required on
the data collection form did not need interpretation or
calculation if collected as a numeric value.
The majority of the data elements, 152 (61%)
required transformation of some type. Cognitively,
transformation means that a rule is required to
change the data value from its source state to the
destination state on the data collection form.
Collection of age on the data collection form is an
example; age would need to be calculated from the
date of birth and the date of the screening visit. The
types of transformation required include comparison,
calculation, interpretation and mapping, shown by
percentage in Table 2. Scale transformations were
counted separately. In addition, 37 (15%) of the data
elements required more than one transformation.
Transformation Type

Percent

Comparison

43%

Mapping (categorization)

29%

Interpretation (also included synthesis)

14%

Calculation

14%

Table 2. Characterization of Transformation

internal assessment of each. Unless external
cognitive support is provided, e.g., a worksheet, or
created by the abstractor, e.g., a scratch pad, the
values for each dimension are held in the abstractor’s
head prior to and during the transformation.
Therefore, the dimension counts indicate the
cognitive load required for the transformation.
Scale mismatch between the represented information,
the abstraction task, and the data collection form
representation further impacted internal cognitive
demands on the abstractor by requiring mental
transformations from one scale to another. Each data
element was categorized three ways according to
Steven’s17 nominal, ordinal, interval, and ratio scales,
1) the scale of the represented information, 2) the
scale of the abstraction task, i.e., the transformation
or transcription, and 3) the scale of the data
collection form representation. Table 3 shows the
overall shift in scale from the represented
information to the data collection form
representation.
Data Collection Form Representation
Nominal

Ordinal

Interval

Ratio

Nominal (138)

138

0

0

0

Ordinal (19)

16

3

0

0

Interval (29)

1

0

28

0

Ratio (64)

23

3

0

38

178

6

28

38

Represented

The data collection form representation for each data
element was assessed and categorized as either
supporting external cognition or not. As expected,
external cognition for the 98 direct transcription data
elements was supported by the data collection form.
For these data elements, the form prompt and field
structure made the search and transcription tasks
perceptually evident, i.e., no additional cognition on
the part of the human abstractor required.

Table 3. Scale “down shift” from Represented
Information to Data Collection Form

Supporting external cognition for the transformation
(rule based) tasks, is more difficult. Unfortunately,
the cognitively more complex data elements, i.e., the
152 data elements requiring transformations, were
not supported by form-based external cognition
artifacts. One hundred and thirteen (74%) of these
complex data elements, required internal cognition.

Overall, 43 (17%) of the data elements were reduced
from the represented information scale to the data
collection form representation. This down shift
requires transformation, usually in the form of
mapping, interpretation, or categorization. Thus,
scale mismatch adds to the already significant
cognitive load on the human abstractor.

The number of dimensions, i.e., individual distinct
pieces of information, for example, using two
dimensions, today’s date and birth date to calculate
today’s age, required for each transformation was
also assessed. The mean number of dimensions
required for abstracting the data elements that needed
a transformation was 2.6, with a range of 1 to 45
dimensions required. For example, an abstractor must
compare, map, interpret, or calculate 45 distinct
pieces of information. The highest number, 45 was a
data element asking for enumeration of inclusion and
exclusion criterion that were not met requiring

Discussion
Although from only a limited evaluation in a small
sample of paper data collection forms, the results
reported here document the significant cognitive
demands in medical record abstraction. A human can
hold on average from 5-7 chunks of information in
working memory18. Our results show that on average,
the cognitive demands for many CRF data elements
bump up against the limits of human cognition.
Further, the 9% of data elements requiring four or
more dimensions, when added to cognitive load from
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transformations, can easily exceed working memory
limits. Moreover, the paper data collection forms
analyzed had few, if any, external cognition artifacts
to support the most cognitively demanding data
elements.
Other authors have cited requiring “abstractor
judgment” or “interpretation” as a cause of errors in
medical record abstraction6, 8, 9, 10. However, none have
suggested why these errors occur or the nature of
their relationship to other types of data error in
medical record abstraction. Likewise, the literature
does not suggest concrete methods of mitigating or
preventing the resulting data errors. Our results
contribute a possible explanation and mechanism for
a portion of the data accuracy problem in medical
record abstraction.
In addition, the theory of
distributed representation and the associated
representational analysis used here can be applied to
analyze data element representation on data
collection forms and abstraction tasks to prevent or
lessen the likelihood of cognitive limit related
abstraction errors. The representational analysis used
here can be performed during form design to identify
high cognitive load data elements and to evaluate
isomorphs. Such an application would improve form
design by identifying high cognitive load data
elements so that they can be replaced with lower
cognitive load isomorphs. Further, both electronic
medical records and electronic data collection forms,
provide additional opportunities for decreasing
cognitive load. Confirming these results in a larger
and more diverse sample of forms and medical
records, and evaluation of data accuracy from data
collection form isomorphs are key next steps in this
area of inquiry.
Conclusion
The cognitive load required for abstraction of 61% of
the data elements in our sample was both high and
unsupported with external cognition artifacts on the
data collection forms, exceedingly so for 9% of the
data elements. The high working memory demands
are a possible explanation for the association of data
errors in medical record abstraction with data
elements that require abstractor interpretation,
comparison, mapping or calculation. Existing
methods of representational analysis can be applied
to identify data elements with high cognitive
demands and help form designers identify and avoid
them in form design. Further, representational
analysis provides a tool to analyze form isomorphs
and identify those with the lowest cognitive
demands.
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